Remo CRO

News

Great Gift moves to Innovation Quarter

09.20 2017.

Jennifer Byrne is the founder of Greater Gift, a nonprofit organization that facilitates the donation of vaccines in honor of clinical research participants. Seeing students walk by every day on the way to class, she envisions the impact that these future doctors, physician assistants and certified nurses can have on their patients—not only through patient care, […] Details

Clinical Research IO unifies eSource with Financial Management for sites

09.20 2017.

Clinical Research IO (CRIO) has just released its Financial Management module, which makes it one of the first eSource systems with integrated receivables and payables tracking for clinical research sites. Managing receivables is a significant pain point for clinical research sites. Some contracts pay by the visit while others pay by the procedure. Some specify […] Details

Catalent to acquire Cook Pharmica for $950M

09.20 2017.

Catalent, a global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has reached an agreement to acquire Bloomington, Indiana-based Cook Pharmica, an integrated provider of drug substance and drug product manufacturing and related services. The purchase price is $950 million, with $750 million to be paid at closing […] Details

Q BioMed partners with Sphaera for pediatric developmental nonverbal disorder

09.20 2017.

Q BioMed (QBIO), a biotechnology acceleration company, announced a partnership with Sphaera Pharma to develop a new and proprietary analog of QBM-001 for pediatric developmental nonverbal disorder. “The goal of our collaboration with Sphaera Pharma is to put the patient first, especially since QBM-001 targets a rare subset of toddlers that become non- or minimally […] Details

FDA approves Aliqopa for adults with relapsed follicular lymphoma

09.19 2017.

The FDA granted accelerated approval to Aliqopa (copanlisib) for the treatment of adults with relapsed follicular lymphoma who have received at least two prior treatments known as systemic therapies. “For patients with relapsed follicular lymphoma, the cancer often comes back even after multiple treatments,” said Richard Pazdur, M.D., director of the FDA’s Oncology Center of […] Details

Aequus, Ehave collaborate on bioinformatics platform

09.19 2017.

Aequus Pharmaceuticals, a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, and Ehave, a healthcare bioinformatics company whose platform efficiently captures, integrates, and delivers high-quality clinical data and treatment tools, have entered into a collaboration whereby Aequus will gain access to Ehave’s bioinformatics platform for use in Aequus’ anticipated clinical […] Details